Trial Profile
Effect of Teriparatide on Femoral Neck Fracture Healing.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Nov 2019
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Hip fracture
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly and Company
- 23 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov record.
- 28 Feb 2013 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 28 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.